Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sodium-dependent phosphate transporter 2 (SLC20A2, PiT-2) is a transmembrane transporter belonging to the solute carrier family, critical for the sodium-dependent uptake of inorganic phosphate. It forms homodimers, operates primarily in the brain and bone, and is essential for normal cellular function, including energy metabolism and nucleic acid synthesis. SLC20A2 also acts as a cell surface receptor for certain retroviruses. Pathogenic mutations cause phosphate metabolism dysfunction and abnormal calcium-phosphate deposition in the brain, notably leading to diseases like primary familial brain calcification (Fahr's syndrome), and are implicated in bone quality and strength. Its dual role in transport and viral entry underscores a diverse functional and clinical significance
For potential drugs: inhibition or modulation of phosphate transport to correct or mitigate abnormal mineralization and calcification. For retroviral entry, blockade of viral-receptor interaction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium-dependent phosphate transporter 2 (SLC20A2).